Perrigo Enhances Board with the Appointment of Two New Independent Directors

Perrigo Appoints Two New Independent Directors

Perrigo Company plc, a prominent player in the consumer health sector, recently announced the appointment of Salman Amin and Omer Gajial to its Board of Directors. Effective from June 30, 2026, this strategic addition reflects the company's commitment to strengthening its governance structure with experienced professionals.

Who Are the New Directors?

Salman Amin

At 66, Salman Amin brings over three decades of executive experience in the global consumer products landscape. His most recent role was as the Chief Executive Officer of pladis Global, where he led significant transformations resulting in sustained revenue growth and enhanced profitability. Throughout his career, he has held vital positions at major companies, including SC Johnson as Chief Operating Officer of the Global Commercial Division and senior roles at PepsiCo and Procter & Gamble. Amin's extensive experience in driving operational excellence and growth will be invaluable as Perrigo continues to push its strategic agenda forward.

Omer Gajial

Omer Gajial, 52, is another distinguished addition to the board. With a robust background in retail, e-commerce, and consumer health, Gajial currently serves as the CEO of GoTo Foods. His leadership extends to overseeing operations at more than 7,000 restaurant and retail locations worldwide. Previously, he held the position of Executive Vice President and Chief Merchandising Digital Officer at Albertsons Companies, where his expertise in digital transformation and merchandising strategies contributed to significant business advancements. A forward-thinker, Gajial's perspective aligns with Perrigo’s goals of enhancing its digital capabilities.

Enhancing Strategic Priorities

Orlando D. Ashford, Chair of the Perrigo Board of Directors, expressed enthusiasm about welcoming both Amin and Gajial. He noted their extensive experience across various domains, particularly in consumer products and digital transformation, which will significantly bolster Perrigo’s strategic objectives. Their profound understanding of market dynamics and operational strategies is expected to provide invaluable guidance as the company continues to refine its offerings in the health sector.

About Perrigo Company

Founded over a century ago, Perrigo Company plc stands as a leading manufacturer of self-care products. The company is dedicated to providing innovative health and wellness solutions primarily in North America and Europe. As a pioneer in the over-the-counter (OTC) self-care market, Perrigo specializes in products that consumers can utilize without prescriptions, ensuring greater accessibility and choice across various health needs. The company’s business model hinges on leveraging a robust portfolio of cash-generative private label brands to invest in well-known ones such as Opill®, Mederma®, Compeed®, EllaOne®, and Jungle Formula®.

By appointing experienced independent directors, Perrigo aims to further enhance its operational, strategic, and governance capacities, positioning itself for future growth and success in the competitive consumer health market. The company remains committed to its mission of delivering reliable health solutions while adhering to the highest standards of quality and accessibility for customers worldwide. As Perrigo continues to evolve and adapt to the dynamic market environment, the integration of new perspectives and expertise will be critical in ensuring its sustained relevance and success in the industry.

For further information about Perrigo and its offerings, visit www.perrigo.com.